Blog - Dr. Dima Abdul Jabbar | Consultant Medical Oncologist in Abu Dhabi

Supporting the Future of Breast Cancer Care: Dr. Dima AbdulJabbar Visits Burjeel Breast Center Al Ain

By developer July 21, 2026July 21, 2026

Dr. Dima AbdulJabbar continues her commitment to advancing breast cancer care through collaboration, strategic planning, and multidisciplinary teamwork. During her recent visit to Burjeel Breast Center Al Ain, she joined colleagues in productive discussions focused on the center’s future development and its vision for expanding comprehensive breast care services. The visit provided an opportunity to exchange clinical perspectives and discuss future plans aimed at strengthening patient-centered breast cancer care. Conversations focused on enhancing multidisciplinary collaboration, integrating the latest evidence-based practices, and supporting continued innovation in breast cancer diagnosis, treatment, and survivorship. Breast Centers play a vital role in delivering coordinated care by bringing together specialists from different disciplines to provide comprehensive evaluation, personalized treatment planning, and ongoing patient support. Continuous planning and collaboration are essential to ensuring that patients benefit from the latest medical advances while receiving high-quality, compassionate care. For Dr. Dima AbdulJabbar, every collaborative meeting represents another step toward improving breast cancer services and advancing excellence in patient care. Through continuous teamwork and strategic development, she remains committed to helping shape the future of comprehensive breast cancer care for patients across the region

Advancing Cancer Care Through Global Collaboration: Dr. Dima AbdulJabbar Attends ASCO 2026

By developer July 20, 2026July 20, 2026

Dr. Dima AbdulJabbar continues to strengthen her commitment to evidence-based oncology through participation in leading international scientific meetings. As part of this commitment, she attended the ASCO Annual Meeting 2026, one of the world’s largest and most influential oncology conferences, bringing together more than 40,000 oncologists, researchers, healthcare professionals, and industry leaders from around the globe. Organized annually by the American Society of Clinical Oncology (ASCO), the meeting serves as a premier international platform for presenting groundbreaking clinical research, discussing advances in cancer diagnosis and treatment, and shaping the future of oncology through scientific collaboration and innovation. The 2026 meeting featured more than 7,000 scientific abstracts, highlighting the rapid pace of progress across virtually every field of cancer care. Among the most significant scientific highlights presented during ASCO 2026 were advances that have the potential to influence future standards of cancer treatment. One of the most closely watched presentations introduced encouraging Phase III data for daraxonrasib, an investigational targeted therapy for advanced pancreatic cancer, demonstrating improved survival outcomes and renewed hope for one of the most challenging cancers to treat. The conference also showcased important progress in breast cancer treatment, with new evidence supporting expanded use of HER2-targeted therapies, including trastuzumab deruxtecan (Enhertu) in selected patient populations. Researchers presented additional data aimed at improving outcomes through earlier intervention and more personalized treatment strategies. Another major focus of ASCO 2026 was the continued evolution of Precision Oncology, where genomic profiling and biomarker-driven treatment selection are transforming the way cancer is diagnosed and managed. Advances in molecular testing are allowing physicians to identify therapies that are tailored to the unique characteristics of each patient’s tumor, helping improve treatment effectiveness while minimizing unnecessary therapies. In addition, experts presented new developments in immunotherapy, targeted therapies, supportive care, cancer prevention, survivorship, and quality-of-life research, reflecting the growing emphasis on delivering more personalized, effective, and patient-centered cancer care. For Dr. Dima AbdulJabbar, participation in international scientific meetings represents an essential part of continuous professional development. Staying connected with the latest clinical evidence, emerging technologies, and global advances in oncology reinforces her commitment to providing patients with care that reflects the highest international standards and the latest evidence-based treatment approaches.

Strengthening International Collaboration in Cancer Care: Dr. Dima AbdulJabbar Visits Tajikistan

By developer July 18, 2026July 20, 2026

Strengthening International Collaboration in Cancer Care: Dr. Dima AbdulJabbar Visits Tajikistan Dr. Dima AbdulJabbar continues to expand her commitment to advancing cancer care through international collaboration and continuous professional development. As part of this commitment, she recently visited Tajikistan, where she met with medical colleagues and patients in an experience that combined scientific exchange with meaningful human connections. International collaboration plays an increasingly important role in modern oncology. By engaging with healthcare professionals across different countries, physicians have the opportunity to exchange expertise, learn from diverse clinical experiences, and explore emerging technologies that continue to shape the future of cancer diagnosis and treatment. The visit also provided an opportunity to gain insight into evolving approaches and modern technologies in oncology, reinforcing the importance of continuous learning and global cooperation in delivering high-quality, patient-centered cancer care. Reflecting on the visit, Dr. Dima AbdulJabbar shared: “From Tajikistan… unforgettable moments with colleagues and patients. Every conversation, every smile, and every shared experience made this journey truly meaningful.” For Dr. Dima AbdulJabbar, every international medical experience represents another step toward strengthening clinical knowledge, encouraging collaboration, and bringing the latest evidence-based practices to patients. She remains committed to continuous education and embracing innovation that supports better outcomes for individuals affected by cancer.

Best of ESMO Breast Cancer UAE

By developer October 2, 2025October 2, 2025

Dr. Dima Abduljabbar participated in the prestigious Best of ESMO Breast Cancer UAE 2023, a significant event in the oncology field dedicated to sharing the latest advancements in breast cancer care. This annual meeting, held in collaboration with the European Society for Medical Oncology (ESMO), brought together experts and healthcare professionals from across the region to review and discuss key highlights from the international ESMO Breast Cancer Congress 2023. The event focused on translating cutting-edge research into clinical practice, with a strong emphasis on improving access to high-quality cancer care across the UAE. Dr. Dima Abduljabbar’s involvement reflects her ongoing commitment to medical education, evidence-based treatment, and the continuous enhancement of patient outcomes in the region. As part of a broader effort to support innovation and excellence in oncology, the event also emphasized the importance of research, multidisciplinary collaboration, and policy development to meet the growing needs of cancer patients.

Circle of Hope: A Survivorship Gathering

By developer September 30, 2025October 2, 2025

Location: Burjeel Medical Center – Pendulum Hall Dr. Dima Abduljabbar participated in the Circle of Hope: A Survivorship Gathering, an inspiring and supportive event dedicated to empowering individuals who have completed their cancer treatment journey. This gathering provided a compassionate space for survivors and their families to reconnect with themselves, their bodies, and their community — embracing life beyond treatment. The event featured expert-led sessions on mind-body wellness, post-treatment recovery, nutrition, emotional resilience, and intimacy. With guidance from leading healthcare professionals, the program was designed to offer practical tools and uplifting insights for survivors seeking to restore strength, confidence, and holistic health. Dr. Dima Abduljabbar contributed to the session titled “Strong Bones, Strong You,” where she spoke about the importance of bone health during and after cancer treatment — a critical but often overlooked aspect of survivorship. Her guidance highlighted the long-term impact of certain cancer therapies on bone density, and shared effective strategies for protecting bone strength through nutrition, lifestyle, and medical support. Throughout the gathering, attendees had the opportunity to engage in thoughtful discussions, explore supportive therapies, and celebrate resilience with others who understand the journey firsthand. The Circle of Hope stands as a testament to the healing power of community, education, and compassionate care — and reflects Dr. Abduljabbar’s continued commitment to whole-person wellness and patient empowerment beyond clinical treatment.

Pregnancy and Breast Cancer: Updated Clinical Guidelines Shape a New Standard of Care

By developer September 9, 2025October 2, 2025

Published: September 2025 Dr. Dima Abduljabbar continues to remain at the forefront of evidence-based care with a focus on complex cases at the intersection of oncology and women’s health. One area gaining renewed attention is the management of breast cancer during pregnancy, highlighted in the latest release of Green-top Guideline No. 12, developed to provide clear, multidisciplinary guidance for clinicians treating this rare but serious condition. Breast cancer is the most common cancer affecting women in the UK and many other parts of the world, with about 9% of cases diagnosed in women aged 44 and under. As more women choose to delay pregnancy, the incidence of breast cancer during pregnancy is expected to rise. Currently, 1 in 3000 pregnancies is complicated by a new diagnosis of breast cancer. Green-top Guideline No. 12—now in its third edition—addresses the nuanced care required for this unique patient population. The guideline offers a comprehensive framework for diagnosing, managing, and treating breast cancer during and immediately after pregnancy. It also includes long-term considerations for fertility preservation and family planning in women with a past breast cancer diagnosis. “These updated guidelines represent a significant step forward in supporting women who face both the joys and fears of pregnancy while battling or recovering from breast cancer,” said Dr. Dima Abduljabbar. “Our clinical decisions must be both safe and sensitive—tailored not only to cancer outcomes but also to maternal and fetal health.” Key topics from the guideline include: Diagnostic pathways that minimize fetal risk Timing and selection of chemotherapy during pregnancy Safe surgical options and anesthesia considerations Breastfeeding recommendations Fertility preservation strategies prior to cancer treatment For Dr. Dima Abduljabbar, integrating such guidelines into her clinical practice is essential. She is committed to providing compassionate, state-of-the-art care to women navigating reproductive decisions amid cancer diagnoses. As breast cancer survival rates continue to improve—with 85% of women under 39 surviving at least five years post-diagnosis—more patients are considering pregnancy after cancer. This evolving reality requires not only medical expertise but also a deep understanding of emotional, ethical, and lifestyle factors involved.

Supporting the Future of Breast Cancer Care: Dr. Dima AbdulJabbar Visits Burjeel Breast Center Al Ain

Advancing Cancer Care Through Global Collaboration: Dr. Dima AbdulJabbar Attends ASCO 2026

Strengthening International Collaboration in Cancer Care: Dr. Dima AbdulJabbar Visits Tajikistan

Best of ESMO Breast Cancer UAE

Circle of Hope: A Survivorship Gathering

Pregnancy and Breast Cancer: Updated Clinical Guidelines Shape a New Standard of Care

Subscribe To Our Newsletter

Follow us on our social media for daily updates.

About Us

Useful Links

Copyright © Dima Abdul Jabbar. All rights reserved